Association of Vitamin D With Insulin Resistance and  -Cell Dysfunction in Subjects at Risk for Type 2 Diabetes: Response to Muscogiuri et al (original) (raw)

Abstract

OBJECTIVE -To examine cross-sectional associations of serum vitamin D [25hydroxyvitamin D, 25(OH)D] concentration with insulin resistance (IR) and ␤-cell dysfunction in 712 subjects at risk for type 2 diabetes.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (15)

  1. Ozfirat Z, Chowdhury TA. Vitamin D de- ficiency and type 2 diabetes. Postgrad Med J 2010;86:18 -25
  2. Gulseth HL, Gjelstad IM, Tierney AC, Lovegrove JA, Defoort C, Blaak EE, Lopez-Miranda J, Kiec-Wilk B, Ris U, Roche HM, Drevon CA, Birkeland KI. Se- rum vitamin D concentration does not predict insulin action or secretion in Eu- ropean subjects with the metabolic syn- drome. Diabetes Care 2010:33;923-925
  3. Chiu KC, Chu A, Go VL, Saad MF. Hypo- vitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820 -825
  4. Scragg R, Sowers M, Bell C, Third Na- tional Health and Nutrition Examina- tion Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Exami- nation Survey. Diabetes Care 2004;27: 2813-2818
  5. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hy- droxy vitamin d is predictive of future gly- cemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990 -2000. Diabetes 2008;57: 2619 -2625
  6. Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, Jacques PF. Plasma 25-hydroxyvitamin D is associ- ated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009;139:329 -334
  7. Zhao G, Ford ES, Li C. Associations of serum concentrations of 25-hydroxyvita- min D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-di- agnosed diabetes: NHANES, 2003-2006. Diabetes Care 2010;33:344 -347
  8. Hanley AJ, Retnakaran R, Qi Y, Gerstein HC, Perkins B, Raboud J, Harris SB, Zin- man B. Association of hematological pa- rameters with insulin resistance and beta- cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab 2009;94:3824 - 3832
  9. Matsuda M, DeFronzo RA. Insulin sensi- tivity indices obtained from oral glucose tolerance testing: comparison with the eu- glycemic insulin clamp. Diabetes Care 1999;22:1462-1470
  10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Ho- meostasis model assessment: insulin re- sistance and beta-cell function from fasting plasma glucose and insulin con- centrations in man. Diabetologia 1985; 28:412-419
  11. Wareham NJ, Phillips DI, Byrne CD, Hales CN. The 30 minute insulin incre- mental response in an oral glucose toler- ance test as a measure of insulin secretion. Diabet Med 1995;12:931
  12. Retnakaran R, Qi Y, Goran MI, Hamilton JK. Evaluation of proposed oral disposi- tion index measures in relation to the ac- tual disposition index. Diabet Med 2009; 26:1198 -1203
  13. Wu T, Willett WC, Giovannucci E. Plasma C-peptide is inversely associated with calcium intake in women and with plasma 25-hydroxy vitamin D in men. J Nutr 2009;139:547-554
  14. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in rela- tion to vitamin D deficiency in east Lon- don Asians. Diabetologia 1995;38:1239 - 1245
  15. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O'Donnell CJ, Hoffmann U, Jacques PF, Booth SL, Vasan RS, Wolf M, Wang TJ. Adiposity, cardiometabolic risk, and vita- min D status: the Framingham Heart Study. Diabetes 2010;59:242-248